| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
2e-08 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
3e-08 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-08 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.31 |
5e-08 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
2e-07 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-07 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-07 |